GSTM1 and Schnyder corneal dystrophy: The pharmacodynamic parameters, such as transduction efficiency, the total Hb level, and the HbAT87Q levels, are sensitive and early predictors of the clinical response of SCD patients to Lovo-Cel-based gene therapy [36].